Specify a stock or a cryptocurrency in the search bar to get a summary
Getein Biotech Inc
603387Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China. Address: No.9 Bofu Road, Nanjing, China, 211505
Analytics
WallStreet Target Price
270.33 CNYP/E ratio
17.74Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 603387
Dividend Analytics 603387
Dividend growth over 5 years
83 %Continuous growth
–Payout Ratio 5 years average
29 %Dividend History 603387
Stock Valuation 603387
Financials 603387
Results | 2019 | Dynamics |